Evidence for Distinct Antagonist-Revealed Functional States of 5-Hydroxytryptamine2A Receptor Homodimers

被引:45
作者
Brea, Jose [1 ]
Castro, Marian [1 ]
Giraldo, Jesus [2 ,3 ]
Lopez-Gimenez, Juan F. [4 ]
Fernando Padin, Juan [1 ]
Quintian, Fatima [1 ]
Isabel Cadavid, Maria [1 ]
Teresa Vilaro, Maria [5 ]
Mengod, Guadalupe [4 ,5 ]
Berg, Kelly A. [6 ]
Clarke, William P. [6 ]
Vilardaga, Jean-Pierre [7 ,8 ,9 ]
Milligan, Graeme
Isabel Loza, Maria [1 ]
机构
[1] Univ Santiago de Compostela, Dept Farmacol, Inst Farm Ind, Fac Farm, Santiago De Compostela, Spain
[2] Univ Autonoma Barcelona, Inst Neurociencies, Bellaterra, Spain
[3] Univ Autonoma Barcelona, Unitat Bioestadist, Bellaterra, Spain
[4] Univ Glasgow, Dept Biochem & Mol Biol, Glasgow, Lanark, Scotland
[5] IDIBAPS, Consejo Super Invest Cient, Inst Invest Biomed Barcelona, Dept Neurochem & Neuropharmacol, Barcelona, Spain
[6] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA
[7] Univ Pittsburgh, Med Ctr, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA
[8] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
[9] Harvard Univ, Sch Med, Boston, MA USA
关键词
PROTEIN-COUPLED RECEPTOR; RESONANCE ENERGY-TRANSFER; BETA-ADRENERGIC-RECEPTOR; TERNARY COMPLEX MODEL; INVERSE AGONISTS; LIGAND-BINDING; LIVING CELLS; BETA(2)-ADRENERGIC RECEPTOR; CONFORMATIONAL-CHANGES; MEMBRANE MICRODOMAINS;
D O I
10.1124/mol.108.054395
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The serotonin (5-hydroxytryptamine; 5-HT) 2A receptor is a cell surface class A G protein-coupled receptor that regulates a multitude of physiological functions of the body and is a target for antipsychotic drugs. Here we found by means of fluorescence resonance energy transfer and immunoprecipitation studies that the 5-HT2A-receptor homodimerized in live cells, which we linked with its antagonist-dependent fingerprint in both binding and receptor signaling. Some antagonists, like the atypical antipsychotics clozapine and risperidone, differentiate themselves from others, like the typical antipsychotic haloperidol, antagonizing these 5-HT2A receptor-mediated functions in a pathway-specific manner, explained here by a new model of multiple active interconvertible conformations at dimeric receptors.
引用
收藏
页码:1380 / 1391
页数:12
相关论文
共 61 条
[31]   β-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis [J].
Hunton, DL ;
Barnes, WG ;
Kim, J ;
Ren, XR ;
Violin, JD ;
Reiter, E ;
Milligan, G ;
Patel, DD ;
Lefkowitz, RJ .
MOLECULAR PHARMACOLOGY, 2005, 67 (04) :1229-1236
[32]   Opinion - Drugs, their targets and the nature and number of drug targets [J].
Imming, Peter ;
Sinning, Christian ;
Meyer, Achim .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (10) :821-834
[33]   [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P acts as a biased agonist toward neuropeptide and chemokine receptors [J].
Jarpe, MB ;
Knall, C ;
Mitchell, FM ;
Buhl, AM ;
Duzic, E ;
Johnson, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :3097-3104
[34]   AGONIST-RECEPTOR EFFICACY .2. AGONIST TRAFFICKING OF RECEPTOR SIGNALS [J].
KENAKIN, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (07) :232-238
[35]   Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors [J].
Kenakin, Terry .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (08) :407-415
[36]   Collateral efficacy in new drug discovery [J].
Kenakin, Terry .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (08) :359-361
[37]  
KENT RS, 1980, MOL PHARMACOL, V17, P14
[38]   Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors [J].
Knight, AR ;
Misra, A ;
Quirk, K ;
Benwell, K ;
Revell, D ;
Kennett, G ;
Bickerdike, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (02) :114-123
[39]   THE 2-STATE MODEL OF RECEPTOR ACTIVATION [J].
LEFF, P .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (03) :89-97
[40]   A three-state receptor model of agonist action [J].
Leff, P ;
Scaramellini, C ;
Law, C ;
McKechnie, K .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (10) :355-362